ISDA

Deposition Date 2019-06-06

Release Date 2020-01-15

Last Version Date 2024-03-13

Entry Detail

PDB ID:

6P7Z

Keywords:

TRANSFERASE/TRANSFERASE INHIBITOR

Title:

Co-crystal Structure of human SMYD3 with Isoxazole Amides Inhibitors

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

unidentified baculovirus

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.19 Å

R-Value Free:

0.19

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Histone-lysine N-methyltransferase SMYD3
Gene (Uniprot):SMYD3
Chain IDs:A
Chain Length:432
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q9H7B4 Pfam ID:PF00856, PF01753 EC:2.1.1.354

Ligand Molecules

O41

SAM

Primary Citation

Discovery of Isoxazole Amides as Potent and Selective SMYD3 Inhibitors.

Su, D.S, Qu, J, Schulz, M, Blackledge, C.W, Yu, H, Zeng, J, Burgess, J, Reif, A, Stern, M, Nagarajan, R, Pappalardi, M.B, Wong, K, Graves, A.P, Bonnette, W, Wang, L, Elkins, P, Knapp-Reed, B, Carson, J.D, McHugh, C, Mohammad, H, Kruger, R, Luengo, J, Heerding, D.A, Creasy, C.L.Show

Acs Med.Chem.Lett. 11 133 140 (2020)

PMID: 32071679 DOI: 10.1021/acsmedchemlett.9b00493

Abstact

We report herein the discovery of isoxazole amides as potent and selective SET and MYND Domain-Containing Protein 3 (SMYD3) inhibitors. Elucidation of the structure-activity relationship of the high-throughput screening (HTS) lead compound 1 provided potent and selective SMYD3 inhibitors. The SAR optimization, cocrystal structures of small molecules with SMYD3, and mode of inhibition (MOI) characterization of compounds are described. The synthesis and biological and pharmacokinetic profiles of compounds are also presented.

Legend

Protein

Chemical

Disease

Primary Citation of related structures